GSK has acquired RAPT Therapeutics
Further information can be found in the latest press release.
COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES
RAPT Therapeutics Appoints Lisa Butterfield, Ph.D., and Lawrence Fong, M.D., to Scientific Advisory Board
October 14, 2020
« back to news page
You are leaving RAPT.com to go to the eczema clinical trial study site.
